Abstract:BACKGROUND: Patients of cerebral hemorrhage usually suffer from serious defect of nervous function. Researches regarding its pathogenesis gradually go in depth at present, which are for the effective method in the improvement of prognosis.OBJECTIVE: To explore whether intracerebral local medication could reduce dose and improve effectiveness and whether intracerebral local medication has local dose-effect relationship through the local application of Ganglioside GM-1 in intracerebral hematoma cavity.DESIGN: A randomized and controlled trail.SETTING: Department of Neurosurgery and Department of Instruments, the Second Hospital Xi' an Jiaotong University.MATERIALS: Study was performed in the Researching Center of Neurobiology, Faculty of Medicine, Xi' an Jiaotong University from August 2000 to April 2001. Healthy male SD rats with a body mass between 250 g and 300g were obtained from the experimental animal center of Institute for Tradltional Chinese Medicine, Shaanxi Province.INTERVENTIONS: Rats were randomly divided into four groups: ①sham-operation group( n = 12): Puncture into right caudate nucleus was performed; ② model group( n = 12): 50 pL of autologous blood without anti-coagulation was injected into right caudate nucleus; ③ local medication groups: divided into high-dose, middle-dose, and low-dose subgroups( n = 12of each) . 2 mg/kg, 0. 8 mg/kg or 0. 32 mg/kg of GM-1 was injected respectively into the intracerebral hematoma cavity in rats of the corresponding subgroups at 6 hours after the establishment of animal model. The quantity of the solution was calculated with 2 mg/kg and the deficient part of the solution was fetched up with control solution(i. e., the solvent of GM-1 injection solution, confect based on the instructor) . Same volume of control solution was injected into caudate vein simultaneously in rats of medication groups; ④ general medication group( n = 12): 2 mg/kg of GM-1 was injected into caudate vein at 6 hours after the establishment of the animal model and the control solution of same volume was injected into right candate nucleus as well. Rats of the above groups were executed at 72 hours after cerebral hemorrhage for the detection of brain water content(8 rats were taken from each group), the examination of histology(4 rats were taken from each group), and the calculation of the comparative counting of neuron loss.MAIN OUTCOME MEASURES: ① brain water content; ② histological observation; ③ comparative counting of neuron loss.RESULTS: Brain water content in rats of intracerebral local medication high-dose subgroup was(79.77 ±0.94)%, which was significantly lower than(81.42 ±0. 87)% of general medication group( P =0.02) . There was no linear relationship between brain water content and dose in intracerebral local medication groups after linear regression analysis( P = 0. 001 ). Comparative counting of neuron loss in rats of intracerebral local medication high-dose subgroup was(324.00 ± 3.65), which was significantly lower than (344.00 ± 8.83 ) of general medication group ( P = 0. 003 ). Histological observation indicated that survived neurons were significantly more in intracerebral local medication high and middle-dose subgroups than low-dose subgroup.CONCLUSION: With same dose, intracerebral local application of Ganglioside GM-1 can significantly improve therapeutic effectiveness, which gradually increases with the increase of local medication dose, although there is no linear relationship between dose and effect.

Changes of neutral glycosylsphingolipid in stress-induced hypertensive rats after focal cerebral ischemia and the study of exogenous GM1 ganglioside effect on the ischemia

Alterations in expression of GFAPmRNA and correlated protein after cerebral ischemia/reperfusion in rats

GM1 stabilizes expression of NMDA receptor subunit 1 in the ischemic hemisphere of MCAo/reperfusion rat

Effect of Gangliaside GM1 on Induced Nitric Oxide Synthase after Focal Cerebral Ischemical Reperfusion in Rats

Identification of differentially expressed proteins and validation of the changes of N-ethylmaleimide-sensitive factor in rats with focal cerebral ischemia after transection of the cervical sympathetic trunk

Protection Against Experimental Stroke by Ganglioside GM1 is Associated with the Inhibition of Autophagy

Effect of gangliaside GM-1 on nitric oxide synthase after focal cerebral ischemia in rats

Temporal changes in edema, Na+, K+, and Ca++ in focal cortical stroke: GM1 ganglioside reduces ischemic injury

Influence of cerebral ischemia-reperfusion injury on myelin-associated glycoprotein expression in rats

GM1 ameliorates neuronal injury in rats after cerebral ischemia and reperfusion: Potential contribution of effects on SPTBN1-mediated signaling

Imaging Mass Spectrometry Detection of Gangliosides Species in the Mouse Brain Following Transient Focal Cerebral Ischemia and Long-Term Recovery

Monosialoganglioside Protected Ischemic Rat Hippocampal Slices Through Stabilizing Expression of N-Methyl-D-Aspartate Receptor Subunit

Effects of Ganglioside GM1 on Reduction of Brain Edema and Amelioration of Cerebral Metabolism after Traumatic Brain Injury.

Effect of hydroxysafflor yellow A on the activity of astrocytes in cerebral ischemic/reperfusion in rats

Ganglioside GM1 and Central Nervous System Diseases

A Study on Monosialotetra Hexosyl Ganglioside in the Treatment of Acute Cerebral Infarction

Neuroprotective Effect of Ganoderic Acid against Focal Ischemic Stroke Induced by Middle Cerebral Artery Occlusion in the Rats via Suppression of Oxidative Stress and Inflammation

[Study on Protective Effect of Monosialoganglioside (GM1) on Injury Induced by Oxygen Glucose Deprivation/reperfusion in Rat Hippocampal Slices].

Effects and mechanism of the local application of Ganglioside GM-1 in intracerebral hematoma cavity for the treatment of experimental cerebral hemorrhage

Action mechanism of early cerebral injuries after spontaneous subarachnoid hemorrhage by silence Ghrelin and angiogenic factor with G-patch and FHA domain 1

Evaluation of the Clinical Effect in the Treatment of Acute Cerebral Infarctions with ShiJieYin(GM_1)